Loading companies…
Loading companies…
India · Biotech
Develops tunable, regenerative exosome therapies for tissue health, disease, and degeneration
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series B | $18M | Ashish Kacholia — Role not disclosedAvinya Fund — Role not disclosedBurman Family — Role not disclosedGalentic Pharma — Role not disclosedNoblevast Advisory — Role not disclosedProtons Corporate — Role not disclosed |